Intelligence Platform
Patents
Browse 406 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6316404
Treating NIDDM with RXR agonists
expired patentUS 6309639
Method for inhibiting an inflammatory response using antibodies to P-selectin glycoprotein
expired patentUS 6309854
Polynucleotides encoding ligands of the neuropeptide receptor HFGAN72
expired patentUS 6306851
Cyclocarbamate and cyclic amide derivatives
expired patentUS 6270984
Modulating robo: ligand interactions
expired patentUS 6265564
Expressed ligand-vascular intercellular signalling molecule
expired patentUS 6266622
Nuclear receptor ligands and ligand binding domains
expired patentUS 6235878
Fas ligand-like protein, its production and use
expired patentUS 6228862
Treating NIDDM with RXR agonists
expired patentUS 6218430
Vitamin D3 mimics
expired patentUS 6211200
Metal complexes
expired patentUS 6177547
Antibodies to P-selectin glycoprotein ligand
expired patentUS 6166185
Antibodies to human TIE-2 ligands
expired patentUS 6159994
Histamine H.sub.3 receptor ligands
expired patentUS 6117867
Substituted 6-R-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetizing, cardiovascu
expired patentUS 6068976
Modulators of ob gene and screening methods therefor
expired patentUS 6046015
Modulating Robo: ligand interactions
expired patentUS 6042833
Cellular internalization of pIgR stalk and associated ligands
expired patentUS 6028052
Treating NIDDM with RXR agonists
expired patentUS 6028068
Substituted 6H-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetising, cardiovascul
expired patentUS 6022694
Assay for ligands to tyrosine kinase receptors
expired patentUS 6011002
Circularly permuted ligands and circularly permuted chimeric molecules
expired